ABT vs DTSS · P/E 25, rev $44.33B vs rev $24.0M
Abbott Laboratories (ABT) versus Datasea Inc (DTSS) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Datasea Inc (DTSS) is a software - infrastructure company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported DTSS revenue for 2024-06-30 was $24.0M. Net income was -$10.7K. Revenue was up 558.6% from 2023-06-30 to 2024-06-30. DTSS currently screens at market cap $15.3M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. DTSS currently screens at market cap $15.3M.
Not investment advice. Open the ABT and DTSS stock pages for the full models.
Not investment advice.